NASDAQ · FOFO

Hang Feng Technology Innovation Co.., Ltd.

$1.99 -$0.01 (-0.50%) 1D Market open

Key Metrics

$15.14M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$1.29M
Beta · 1Y 0.84
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Jun 3 high, the share price fell 70%.

    Peak close $6.59 on Jun 3; trough close $2.00 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -70%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 3
    The stock moved +64.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 3
  • Jun 1
    The stock moved +41.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 1

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$15.14M
Enterprise value
Shares outstanding7.6M
52-wk range$1.75 – $68.00
Avg volume · 20D186.4K
Net cash
Book value / share$1.13
ExchangeNASDAQ
About Hang Feng Technology Innovation Co.., Ltd.
IPO dateSep 12, 2025
Employees14

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio32.97
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$7.41M

Cash Flow · TTM

Operating CF −$1.29M
Capex −$886
Free cash flow −$1.29M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

Needs two fiscal years of filings

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings